Regis Healthcare Ltd (ASX: REG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Regis Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Regis Healthcare Ltd (ASX: REG)
Latest News
Broker Notes
2 ASX shares to buy with strong long-term growth plans
52-Week Highs
6 ASX 300 shares that hit new 52-week highs today
Share Gainers
Why Develop Global, Ioneer, Regis Healthcare, and Zip shares are racing higher today
Healthcare Shares
Up 124% in a year, ASX 300 healthcare share lifts off on $35 million acquisition
Healthcare Shares
'Next decade is likely to be a golden era' for ASX shares in this sector
Share Gainers
This ASX All Ords share has sneakily climbed 128% over the past year
Earnings Results
ASX healthcare stock sees green after 30% sales growth in FY24
Healthcare Shares
Guess which ASX healthcare stock is rocketing 5% today (hint: not ResMed!)
52-Week Highs
3 ASX healthcare shares smashing new 52-week highs today
Broker Notes
Leading brokers name 3 ASX shares to buy today
Value Investing
Looking for ASX value shares? Here's 1 I'd buy and 1 I'd avoid!
Share Market News
2 ASX healthcare shares with 'significant growth opportunities'
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
10 Sep 2024 | $0.0664 | 50.00% | Final | 25 Sep 2024 |
14 Mar 2024 | $0.0628 | 50.00% | Interim | 11 Apr 2024 |
12 Sep 2023 | $0.0748 | 50.00% | Final | 27 Sep 2023 |
16 Mar 2023 | $0.0200 | 50.00% | Interim | 14 Apr 2023 |
15 Sep 2022 | $0.0232 | 50.00% | Final | 30 Sep 2022 |
10 Mar 2022 | $0.0352 | 50.00% | Interim | 08 Apr 2022 |
15 Sep 2021 | $0.0463 | 50.11% | Final | 30 Sep 2021 |
10 Mar 2021 | $0.0200 | 50.00% | Interim | 08 Apr 2021 |
11 Mar 2020 | $0.0402 | 50.00% | Interim | 30 Sep 2020 |
11 Sep 2019 | $0.0711 | 100.00% | Final | 26 Sep 2019 |
13 Mar 2019 | $0.0812 | 100.00% | Interim | 11 Apr 2019 |
11 Sep 2018 | $0.0865 | 100.00% | Final | 26 Sep 2018 |
13 Mar 2018 | $0.0928 | 100.00% | Interim | 11 Apr 2018 |
01 Sep 2017 | $0.0000 | 100.00% | Final | 18 Sep 2017 |
03 Mar 2017 | $0.1030 | 100.00% | Interim | 20 Mar 2017 |
02 Sep 2016 | $0.0594 | 100.00% | Final | 19 Sep 2016 |
03 Mar 2016 | $0.0940 | 100.00% | Interim | 21 Mar 2016 |
03 Mar 2004 | $0.0700 | 100.00% | Interim | 24 Mar 2004 |
REG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Regis Healthcare Ltd
Regis Healthcare Ltd provides residential care for the elderly in Australia, including respite, dementia-specific, and palliative care. The Company's principal activity is the provision of residential aged care services The firm's facilities are majorly located in metropolitan areas and a majority of its rooms offered are single bedrooms. The majority of Regis' revenue comes from government funding due to the extremely regulated environment for aged care facilities in Australia, though the firm also receives resident fees.
REG Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
11 Oct 2024 | $6.47 | $0.02 | 0.31% | 510,725 | $6.44 | $6.49 | $6.33 |
10 Oct 2024 | $6.45 | $-0.04 | -0.62% | 2,312,924 | $6.50 | $6.54 | $6.44 |
09 Oct 2024 | $6.49 | $0.06 | 0.93% | 540,745 | $6.42 | $6.52 | $6.35 |
08 Oct 2024 | $6.43 | $-0.06 | -0.92% | 498,343 | $6.47 | $6.51 | $6.40 |
07 Oct 2024 | $6.49 | $0.12 | 1.88% | 296,068 | $6.37 | $6.49 | $6.33 |
04 Oct 2024 | $6.37 | $-0.06 | -0.93% | 539,968 | $6.39 | $6.39 | $6.31 |
03 Oct 2024 | $6.43 | $0.13 | 2.06% | 872,789 | $6.33 | $6.46 | $6.26 |
02 Oct 2024 | $6.30 | $0.06 | 0.96% | 773,348 | $6.23 | $6.32 | $6.16 |
01 Oct 2024 | $6.24 | $0.05 | 0.81% | 446,196 | $6.18 | $6.24 | $6.14 |
30 Sep 2024 | $6.19 | $-0.03 | -0.48% | 893,242 | $6.24 | $6.36 | $6.16 |
27 Sep 2024 | $6.22 | $0.02 | 0.32% | 805,098 | $6.20 | $6.23 | $6.13 |
26 Sep 2024 | $6.20 | $0.06 | 0.98% | 1,465,254 | $6.15 | $6.23 | $6.11 |
25 Sep 2024 | $6.14 | $-0.07 | -1.13% | 850,704 | $6.23 | $6.24 | $6.08 |
24 Sep 2024 | $6.21 | $0.05 | 0.81% | 863,076 | $6.15 | $6.24 | $6.08 |
23 Sep 2024 | $6.16 | $0.23 | 3.88% | 2,149,980 | $5.90 | $6.17 | $5.87 |
20 Sep 2024 | $5.93 | $0.10 | 1.72% | 2,121,083 | $5.90 | $6.12 | $5.87 |
19 Sep 2024 | $5.83 | $0.09 | 1.57% | 754,612 | $5.82 | $5.89 | $5.77 |
18 Sep 2024 | $5.74 | $0.02 | 0.35% | 1,148,481 | $5.72 | $5.81 | $5.67 |
17 Sep 2024 | $5.72 | $-0.01 | -0.17% | 561,457 | $5.90 | $5.90 | $5.66 |
16 Sep 2024 | $5.73 | $-0.02 | -0.35% | 821,518 | $5.84 | $5.93 | $5.66 |
13 Sep 2024 | $5.75 | $0.34 | 6.28% | 1,650,111 | $5.60 | $5.95 | $5.52 |
12 Sep 2024 | $5.41 | $0.25 | 4.84% | 1,359,220 | $5.20 | $5.44 | $5.18 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
27 Sep 2024 | Linda Mellors | Cancelled | 39,889 | $245,565 |
Cancellation of securities. Cessation of performance rights, 758,215 Rights
|
27 Sep 2024 | Linda Mellors | Issued | 18,163 | $112,973 |
Issue of securities. 776,378 Rights (unquoted)
|
20 Sep 2024 | Linda Mellors | Issued | 71,035 | $421,237 |
Conversion of securities.
|
20 Sep 2024 | Linda Mellors | Exercise | 71,035 | $421,237 |
Conversion of securities. 798,104 Rights
|
30 May 2024 | Bryan Dorman | Sell | 17,500,000 | $68,250,000 |
Off-market trade.
|
28 May 2024 | Sally Freeman | Buy | 52,462 | $207,541 |
On-market trade.
|
06 Mar 2024 | Jodie Leonard | Buy | 8,105 | $29,988 |
On-market trade.
|
06 Mar 2024 | Jodie Leonard | Buy | 5,400 | $19,980 |
On-market trade.
|
20 Dec 2023 | Linda Mellors | Issued | 333,838 | $1,074,958 |
Issue of securities. 869,139 Rights
|
16 Oct 2023 | Linda Mellors | Buy | 39,889 | $100,520 |
On-market trade. 535,301 Rights
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Graham Hodges | Non-Executive DirectorNon-Executive Chairman | Aug 2017 |
Mr Hodges has international experience in the financial services industry with a career spanning more than 40 years. He commenced his career in Commonwealth Treasury, Canberra, where he worked for 10 years before being seconded to the International Monetary Fund in Washington for several years. Graham built an executive career at the Australian and New Zealand Banking Group Limited and was formerly the Deputy Chief Executive Officer, ANZ Banking Group Ltd. He is member of Risk & Compliance Committee.
|
Professor Christine Constance Bennett | Non-Executive Director | Mar 2018 |
Professor Bennett has over 30 years of health industry experience in clinical care and governance, strategic planning, executive management, teaching and research. Christine is also Convenor of the Champions of Change Coalition Health Group. Christine was awarded the title of Emeritus Professor at the University of Notre Dame Australia following her contributions as Deputy Vice Chancellor Enterprise & Partnerships and Dean of Medicine, Sydney for more than 10 years. She is Chair of the Clinical Governance and Care Committee, Member of the Risk and Compliance Committee as well as Property Committee.
|
Mr Bryan Dorman | Non-Executive Director | May 2007 |
Mr Dorman has experience working in and growing enterprises across range of industry sectors, including residential aged care, manufacturing, property development, asset investment and business services. Bryan was a Partner in Melbourne accounting firm Rees Partners from 1977 until 2000. He is Member of the Risk and Compliance Committee and Clinical Governance and Care Committee.
|
Mr Ian Gregory Roberts | Non-Executive Director | May 2007 |
Mr Roberts has over 30 years of experience in the real estate sector including in excess of 20 years in residential aged care. Prior to co-leading the Regis journey, Ian was involved in property development (sub-divisional and commercial) in South East Queensland. As a founding shareholder and Director of Regis (Executive Director prior to 2008), Ian headed up Property with oversight of the development and implementation of the strategy that saw the business grow to more than 4,500 beds nationally. He is Chair of Property Committee.
|
Ms Jodie Lee Leonard | Non-Executive Director | Nov 2023 |
Mr Leonard is currently a non-executive director at ASX-listed Pacific Smiles Group Ltd (ASX:PSQ) and XPON Technologies Group Ltd (ASX:XPN) and in both cases chairs their Nomination and Remuneration Committees. Jodie is also a non-executive director of Barwon Region Water Corporation, a water utility company in Geelong, Victoria.
|
Dr Linda Jane Mellors | Chief Executive OfficerManaging Director | Aug 2019 |
Dr Mellors has over 20 years of executive experience in health and aged care. Prior to joining Regis, Linda held a range of roles in hospital and health systems predominantly in Victoria, as well as a national aged care service. Linda was also the Co-Chair of the Victorian Metropolitan Hospital Chief Executive group.
|
Ms Sally Margaret Freeman | Non-Executive Director | Jan 2022 |
Ms Freeman Chairs Regis Audit, Risk and Compliance Committee. She has experience in governance, risk and audit, with a career spanning over 30 years, culminating in being the Partner in Charge of KPMG Australia's Risk Consulting practice and representing that practice on the international Board. She is Member of the Clinical Governance and Care Committee.
|
Mr Malcolm Peter Ross | Company SecretaryGeneral Counsel | Nov 2021 |
-
|
Rick Rostolis | Chief Financial Officer |
-
|
|
Imtiaz Bhayat | Chief Information Officer |
-
|
|
Carolyn Noumertzis | Chief People Officer |
-
|
|
Malcolm Peter Ross | Company SecretaryGeneral Counsel |
-
|
|
Melissa McDonald | Executive General Manager - Clinical and Care Practice |
-
|
|
Michael Horwood | Executive General Manager - Property |
-
|
|
Filomena Ciavarella | Executive General Manager - Strategy Quality and Improvement |
-
|
|
Gregg Funston | Executive General Manager Operations |
-
|
|
James Theofanis | Executive General Manager Operations |
-
|
|
Michelle Martella | Executive General Manager Support Services |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Ashburn Pty Ltd | 81,910,479 | 27.22% |
Galabay Pty Ltd | 81,910,479 | 27.22% |
Citicorp Nominees Pty Limited | 32,457,153 | 10.79% |
National Nominees Limited | 26,166,710 | 8.70% |
Buttonwood Nominees Pty Ltd | 13,821,392 | 4.59% |
J P Morgan Nominees Australia Pty Limited | 12,853,545 | 4.27% |
Mandala Holdings Pty Ltd | 3,786,200 | 1.26% |
HSBC Custody Nominees (Australia) Limited | 3,707,979 | 1.23% |
Bnp Paribas Noms Pty Ltd | 2,815,335 | 0.94% |
Mr Vincent Michael O'Sullivan | 1,811,300 | 0.60% |
Bki Investment Company Limited | 1,807,428 | 0.60% |
Netwealth Investments Limited | 1,707,139 | 0.57% |
UBS Nominees Pty Ltd | 1,654,330 | 0.55% |
Mr Ross James Johnston | 1,350,000 | 0.45% |
Mrs Julia Michelle Manken & Mr Mike Darren Manken & Miss Jessica Kelly Manken | 1,335,000 | 0.44% |
Ballian Investments Pty Ltd | 787,934 | 0.26% |
Canto Holdings Pty Ltd | 785,548 | 0.26% |
Netwealth Investments Limited i | 700,857 | 0.23% |
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd | 667,638 | 0.22% |
Bertalli Family Foundation Pty Ltd | 600,000 | 0.20% |
Culloden Investments Pty Ltd | 600,000 | 0.20% |
Neweconomy Com Au Nominees Pty Limited | 535,792 | 0.18% |